跳到主要导航 跳到搜索 跳到主要内容

Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers

  • Mei Shi
  • , Xiao Tong Guo
  • , Mao Guo Shu
  • , Fu Lin Chen
  • , Li Wen Li
  • Xijing Hospital
  • Northwest University China

科研成果: 期刊稿件 › 文章 › 同行评审

12 引用 (Scopus)

摘要

Hypoxia is a common phenomenon in human solid tumors and has been considered as an important, independent negative prognostic factor for response to treatment and survival of tumor patients. Hypoxia-inducible factor-1 (HIF-1) is the central transcription factor which is activated by hypoxia and modulates the expression of many genes involved in cell metabolism, proliferation, apoptosis, angiogenesis. Recently, it has been reported that HIF-1 contributes to tumor radioresistance by upregulating survivin expression under hypoxic conditions. Moreover, in hypoxic tumor cells, HIF-1 dependent signal transduction pathway is activated and could be further enhanced by radiation, thereby providing survival signals to adjacent vascular endothelial cells by upregulation of VEGF and bFGF and resulting in tumor radioresistance through vascular radioprotection. Recent research revealed that the stability of HIF-1α, one of the two subunits of HIF-1, determines the whole HIF-1 activity and the C-terminal transactivation domain of HIF-1α could reduce HIF-1 activity when overexpressed in tumor cells by disruption of the assembly of HIF-1 transcription complex. Therefore, we postulate that fusion with protein transduction domains would overcome the inability of C-terminal transactivation domain of HIF-1α to cross cellular membrane. Thus the recombinant fusion proteins could serve as cell-permeable HIF-1 antagonists, function as both inhibitors of tumor angiogenesis and tumor radiosensitizers, and would be widely used in clinical settings to improve tumor response to radiotherapy.

源语言英语
页(从-至)33-35
页数3
期刊Medical Hypotheses
卷69
期1
DOI
出版状态已出版 - 2007
已对外发布是

学术指纹

探究 'Cell-permeable hypoxia-inducible factor-1 (HIF-1) antagonists function as tumor radiosensitizers' 的科研主题。它们共同构成独一无二的学术指纹。

引用此